Entities / Company
Bioverativ.
American biotechnology multinational specializing in therapies for the treatment of haemophilia
- Reports this week
- 0
- Active events
- 0
- Connections
- 8
What's happening
No events on record for Bioverativ yet.
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 8, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sanofi Structural
Bioverativ was acquired by Sanofi and operates as a subsidiary.